“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β Smad Signaling”. 2025. The Review of Diabetic Studies, December, 496-510. https://doi.org/10.70082/y1zx3j95.